A Pharmacist's Guide to the Prevention and Treatment of Diabetic Foot Problems

Litzelman Dk , Slemenda Cw , Langefeld Cd , Hays Lm , Welch Ma , Bild De , Ford Es , Vinicor F. .Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus.Ann Intern Med. 1993;119:36-41

Healthy people 2000: national health promotion and disease prevention objectives. Washington, DC: US Department of Health and Human Services, Public Health Service; 1990:

NIDDK News Release. 1998;:

Lavery La , Armstrong Dg , Vela Sa , Quebe-Deaux Tl , Fleischli Jg. .Practical criteria for screening patients at high risk for diabetic foot ulceration.Arch Intern Med. 1998;158:157-162

5.DesimoneEmTroiaCEastmanS.Diabetic wound care. Supplement to U.S. Pharmacist (Oct)1997:4–15.

Caputo Gm , Cavanagh Pr , Ulbrecht Js , Gibbons Gw , Karchmer Aw. .N Engl J Med. 1994;331:854-860

Lower-extremity complications of diabetes: The importance of prevention in providing high-quality, cost-effective care.Novo Nordisk Pharm.. 1996;:4-17

Maltz Ga .Low-cost program prevents diabetes-related amputations.Pharmacy Today. 1996;2 (5): 10

Birke Ja , Rolfsen Rj. .Evaluation of a self-administered sensory testing tool to identify patients at risk of diabetes-related foot problems.Diabetes Care. 1998;21:23-25

10.LEAP Program Materials, 5445 Point Clair Road, Carville, LA 70721-9607.

11.Feet Can Last a Lifetime, Foot Care for Diabetes Main Page, http://www.niddk.nih.gov/health/diabetes/feet.

12.Prevention and Early Intervention for Diabetic Foot Problems, a research review, http://www.niddk.nih.gov/health/diabetes/feet/feet2/prevent.htm.

13.Foot care in the diabetic patient, patient teaching aid, US Pharmacist1997.

Lower extremity amputations among persons with diabetes mellitus—Washington, 1988.MMWR. 1991;40:737-739

Yeager Ra , Moneta Gl , Edwards Jm , Williamson Wk , McConnell Db , Taylor Lm , Porter Jm. .Predictors of outcome of forefoot surgery for ulceration and gangrene.Am J Surg. 1998;175:388-390

16. Drug Evaluations: Becaplermin, Micromedix, Inc. Vo 96 exp.5/31/98.

17. Regranex Gel 0.001%, information from Ortho-McNeil, Feb 1996.

Slovenkai Mp .Foot problems in diabetes.Medical Clinics of North America. 1998;82:949-971

Avoid amputation if possible in patients with diabetic foot ulcers.Drugs & Ther Perspectives. 1998;11 (3): 13-16